Literature DB >> 793676

Prazosin: the first-dose phenomenon.

R M Graham, I R Thornell, J M Gain, C Bagnoli, H F Oates, G S Stokes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793676      PMCID: PMC1689975          DOI: 10.1136/bmj.2.6047.1293

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  3 in total

1.  Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

Authors:  A J Wood; P Bolli; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

2.  Experience with prazosin in the treatment of patients with severe hypertension.

Authors:  J M Hayes; R M Graham; B P O'Connell; M R Muir; E Speers; T J Humphery
Journal:  Med J Aust       Date:  1976-04-17       Impact factor: 7.738

3.  Letter: Collapse after prazosin hydrochloride.

Authors:  R Gabriel; D Meek; B C Ghosh
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

  3 in total
  34 in total

Review 1.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

2.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 3.  Effects of alpha-adrenoceptor blockers on renal function and blood pressure adjustment in human hypertension.

Authors:  G Leonetti
Journal:  Drugs       Date:  1988       Impact factor: 9.546

4.  Dose-titration study of alfuzosin, a new alpha 1-adrenoceptor blocker, in essential hypertension.

Authors:  S Leto di Priolo; P Priore; G Cocco; C Sfrisi; J L Cazor
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Haemodynamic and pharmacokinetic evaluation of alfuzosin in man. A dose ranging study and comparison with prazosin.

Authors:  M G Scott; A H Deering; M T McMahon; D W Harron; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  A comparison of single doses of bucindolol and oxprenolol in hypertensive patients.

Authors:  J Webster; J C Petrie; O J Robb; M Jamieson; J Verschueren
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

8.  The influence of alpha 1-adrenergic blockade on the acute antihypertensive effect of nifedipine.

Authors:  H E Sluiter; F T Huysmans; T A Thien; R A Koene
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

9.  A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

Authors:  H L Elliott; P A Meredith; D J Sumner; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335

10.  Prazosin, pharmacokinetics and concentration effect.

Authors:  D N Bateman; D C Hobbs; T M Twomey; E A Stevens; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.